Trademark: 86271578
Word
ORIEN
Status
Registered
Status Code
700
Status Date
Tuesday, May 26, 2020
Serial Number
86271578
Registration Number
6064396
Registration Date
Tuesday, May 26, 2020
Mark Type
4000
Filing Date
Monday, May 5, 2014
Published for Opposition
Tuesday, December 17, 2019

Trademark Owner History
M2GEN, CORP. - Original Registrant
Moffitt Genetics Corporation - Original Applicant

Classifications
35 Personnel selection services in the fields of medical and scientific research, namely, selection of patients for clinical cancer therapy studies for others; clinical trial matching services, namely, matching patients who have cancer with organizations conducting or administering clinical trials for medical research
41 medical educational and training services, namely, conducting lectures, seminars, workshops, conferences, internship training programs, fellowship training programs, and medical residency training programs, all in the field of cancer
42 medical, clinical, and scientific research in the field of cancer; Application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; data collection for research purposes, namely, data mining and pattern recognition; designing clinical research studies for others; data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments; scientific and technological services, namely, research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of oncology; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable medical diagnostic and treatment research computer software for use by healthcare professionals; providing an online searchable database for clinical and scientific research in the field of oncology; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting clinical studies in the field of cancer therapy for others; technological and scientific data analysis in the field of oncology; scientific and research consulting services, namely, technical data collection, research analysis and technical reporting of patients' outcomes and resulting prescribing data related thereto in the field of oncology; technological and scientific data analysis in the field of oncology
44 medical evaluation services to collect data about patients related to research, namely, conducting medical evaluations of a patient's general health and fitness to determine whether they can safely participate in clinical trials; healthcare counseling services, namely, providing medical information relating to cancer screening, cancer diagnosis, cancer prognosis, cancer treatment, cancer relapse, palliative care relating to cancer, integrative medicine relating to cancer, and cancer survivorship; healthcare services, namely, providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions

Trademark Events
May 26, 2020
Registered-Principal Register
Apr 23, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 22, 2020
Allowed Principal Register - Sou Accepted
Apr 9, 2020
Statement Of Use Processing Complete
Mar 23, 2020
Use Amendment Filed
Apr 9, 2020
Case Assigned To Intent To Use Paralegal
Mar 23, 2020
Teas Statement Of Use Received
Feb 11, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 17, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 17, 2019
Published For Opposition
Nov 27, 2019
Notification Of Notice Of Publication E-Mailed
Nov 14, 2019
Approved For Pub - Principal Register
Nov 4, 2019
Teas/Email Correspondence Entered
Nov 4, 2019
Correspondence Received In Law Office
Oct 29, 2019
Teas Request For Reconsideration Received
Sep 5, 2019
Notification Of Final Refusal Emailed
Sep 5, 2019
Final Refusal E-Mailed
Sep 5, 2019
Final Refusal Written
Aug 7, 2019
Teas/Email Correspondence Entered
Aug 7, 2019
Correspondence Received In Law Office
Aug 1, 2019
Teas Response To Office Action Received
Apr 8, 2019
Assigned To Examiner
Mar 28, 2019
Notification Of Non-Final Action E-Mailed
Mar 28, 2019
Non-Final Action E-Mailed
Mar 28, 2019
Non-Final Action Written
Mar 7, 2019
Teas/Email Correspondence Entered
Mar 7, 2019
Correspondence Received In Law Office
Feb 28, 2019
Assigned To Lie
Feb 26, 2019
Teas Response To Suspension Inquiry Received
Sep 28, 2018
Report Completed Suspension Check Case Still Suspended
Aug 29, 2018
Automatic Update Of Assignment Of Ownership
Mar 28, 2018
Report Completed Suspension Check Case Still Suspended
Sep 25, 2017
Report Completed Suspension Check Case Still Suspended
Mar 23, 2017
Report Completed Suspension Check Case Still Suspended
Sep 23, 2016
Report Completed Suspension Check Case Still Suspended
Mar 23, 2016
Report Completed Suspension Check Case Still Suspended
Sep 23, 2015
Notification Of Letter Of Suspension E-Mailed
Sep 23, 2015
Letter Of Suspension E-Mailed
Sep 23, 2015
Suspension Letter Written
Sep 11, 2015
Teas/Email Correspondence Entered
Sep 10, 2015
Correspondence Received In Law Office
Sep 10, 2015
Teas Response To Office Action Received
Mar 11, 2015
Notification Of Non-Final Action E-Mailed
Mar 11, 2015
Non-Final Action E-Mailed
Mar 11, 2015
Non-Final Action Written
Feb 21, 2015
Teas/Email Correspondence Entered
Feb 20, 2015
Correspondence Received In Law Office
Feb 20, 2015
Teas Response To Office Action Received
Aug 20, 2014
Notification Of Non-Final Action E-Mailed
Aug 20, 2014
Non-Final Action E-Mailed
Aug 20, 2014
Non-Final Action Written
Aug 19, 2014
Assigned To Examiner
Jun 5, 2014
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 5, 2014
Teas Change Of Owner Address Received
May 16, 2014
New Application Office Supplied Data Entered In Tram
May 8, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24